Companies are testing dozens of similar drugs in cancers of the pancreas, lung, colon and more.
This post first appeared in The New York Times – Business. Read the original article.New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many
The New York Times – Business:
Written by
in